News on the Division of Blood Diseases and Resources

|
Media Availability
WHAT: A scientist from the National Institutes of Health will present promising, early results from a human clinical trial testing a novel gene replacement therapy in people with severe sickle cell disease. Preliminary findings suggest that the approach has an acceptable level of safety and might help patients consistently produce normal red blood...
Microscopic image of sickle cell
|
Research Features
More than 100,000 people in the United States and an estimated 20 million worldwide suffer from sickle cell disease, a group of inherited, often life-threatening blood disorders that wreak havoc on the body. Mainly affecting African-Americans, Hispanics and Asians, the disease is caused by a mutation in the gene that makes oxygen-carrying hemoglobi...
Cure Sickle Cell.
|
Research Feature
When the NHLBI announced the launch of the Cure Sickle Cell Initiative on September 13, many in the sickle cell disease community responded with enthusiasm. Patients, family members, and advocates took to social media and other channels to say they are ready to do their part, starting with spreading the news about the initiative to their neighbors,...